CD8A and ovarian carcinoma: As one of the main obstacles for ovarian cancer immunotherapy is the inefficiency of CD8+ T-cell recruitment to tumors, understanding the mechanisms by which we can manipulate the TME is important in understanding the challenges and limitation of immunotherapy in ovarian cancer and also allows us insight into how to circumvent this in the hope of being able to make therapy more efficacious.